Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Related Research units
Abstract
[This corrects the article DOI: 10.3389/fimmu.2023.1326078.].
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 1664-3224 |
| DOIs | |
| Publication status | Published - 2024 |
| PubMed | 38327519 |
|---|
